Filing Details

Accession Number:
0001171843-22-007662
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-25 16:41:02
Reporting Period:
2022-11-22
Accepted Time:
2022-11-25 16:41:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1738021 Compass Therapeutics Inc. CMPX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1814093 Vered Bisker-Leib C/O Compass Therapeutics, Inc.
80 Guest St., Suite 601
Boston MA 02135
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-22 14,929 $4.19 1,069,985 No 4 S Direct
Common Stock Disposition 2022-11-23 9,569 $4.30 1,060,416 No 4 S Direct
Common Stock Disposition 2022-11-25 2 $4.36 1,060,414 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are included in the Reporting Person's award agreement which allows the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.
  2. The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.30 per share on November 22, 2022 and $4.15 to $4.43 on November 23, 2022. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.